M1c
Showing 1 - 25 of >10,000
Solid Tumor Trial in Kashiwa-shi, Matsuyama-shi, Koto-Ku (M1-c6v1)
Not yet recruiting
- Solid Tumor
- M1-c6v1
-
Kashiwa-shi, Chiba, Japan
- +2 more
Sep 19, 2023
Melanoma Trial in Wollstonecraft, Cairns (tigilanol tiglate)
Recruiting
- Melanoma
- tigilanol tiglate
-
Wollstonecraft, New South Wales, Australia
- +2 more
Oct 6, 2022
Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Tumors Germ Cell and Embryonal Tumors by Histologic Type Tumors Tumors
Not yet recruiting
- Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms
- HX008 + TACE
- +2 more
-
Beijing, Beijing, ChinaBeijing Cancer hospital
Dec 8, 2022
Psychotic Disorders, Executive Dysfunction Trial in Toronto (Strategy Development, Computerized Cognitive Training)
Recruiting
- Psychotic Disorders
- Executive Dysfunction
- Strategy Development
- Computerized Cognitive Training
-
Toronto, Ontario, CanadaUniversity of Toronto Scarborough
Oct 31, 2022
Psychotic Disorders, Schizophrenia and Related Disorders Trial in Scarborough (Cognitive Behavioural Therapy for Psychosis)
Recruiting
- Psychotic Disorders
- Schizophrenia and Related Disorders
- Cognitive Behavioural Therapy for Psychosis
-
Scarborough, Ontario, CanadaUniversity of Toronto Scarborough
Jan 19, 2023
HIV Vaccine, HIV-1-infection Trial in Chapel Hill, Durham (C62, C1C62, Placebo)
Recruiting
- HIV Vaccine
- HIV-1-infection
- C62
- +4 more
-
Chapel Hill, North Carolina
- +1 more
Oct 27, 2022
Chronic Pain, Knee Pain Chronic, Post Operative Pain Trial in Toronto (Vitamin C, Placebo)
Not yet recruiting
- Chronic Pain
- +2 more
- Vitamin C
- Placebo
-
Toronto, Ontario, Canada
- +2 more
Nov 7, 2023
Psychotic Disorders, Schizophrenia Trial in Scarborough (Virtual Cognitive Behavioural Therapy for Psychosis)
Recruiting
- Psychotic Disorders
- Schizophrenia
- Virtual Cognitive Behavioural Therapy for Psychosis
-
Scarborough, Ontario, CanadaUniversity of Toronto Scarborough
Jan 19, 2023
Muscarinic Receptor Occupancy Trial in New Haven (Scopolamine, [11C]EMO ([11C]LSN3172176))
Not yet recruiting
- Muscarinic Receptor Occupancy
- Scopolamine
- [11C]EMO ([11C]LSN3172176)
-
New Haven, ConnecticutYale University
Aug 31, 2023
Patients Treated With STALIF® C or M and Ti or FLX Implants for
Not yet recruiting
- Degenerative Disc Disease
- +3 more
- STALIF®
- (no location specified)
Jan 11, 2023
Sedentary Behavior Trial in Toronto (Online intervention)
Not yet recruiting
- Sedentary Behavior
- Online intervention
-
Toronto, Ontario, CanadaYork University - School of Kinesiology and Health Science
Oct 31, 2023
Healthy Trial in Nottingham (Ref (TF2), Evobrutinib MR-T1, Evobrutinib MR-T2)
Recruiting
- Healthy
- Ref (TF2)
- +8 more
-
Nottingham, United KingdomQuotient Clinical Ltd
Jul 11, 2022
Developmental Language Disorder, Language Delay, Language Development Trial in Oshawa, Toronto (Intervention to address late
Recruiting
- Developmental Language Disorder
- +2 more
- Intervention to address late talking
-
Oshawa, Ontario, Canada
- +1 more
Dec 4, 2023
Gynecologic Oncology Patients
Not yet recruiting
- Gynecologic Cancer
- +2 more
- Clinical Frailty Scale
- Frailty Phenotype
-
Hamilton, Ontario, Canada
- +2 more
Feb 10, 2023
Infection Trial in Canada (Fecal Microbiota Transplantation (FMT))
Suspended
- Infection
- Fecal Microbiota Transplantation (FMT)
-
Brampton, Ontario, Canada
- +12 more
Nov 1, 2022
HIV Trial in Oxford (ChAdOx1.tHIVconsv1 (C1), MVA.tHIVconsv3 (M3), MVA.tHIVconsv4 (M4))
Completed
- HIV
- ChAdOx1.tHIVconsv1 (C1)
- +2 more
-
Oxford, United KingdomCentre for Clinical Vaccinology and Tropical Medicine, Churchill
Aug 10, 2022
Malaria, Falciparum Trial in Oxford (Matrix M with R78C and/or RH5.1)
Not yet recruiting
- Malaria, Falciparum
- Matrix M with R78C and/or RH5.1
-
Oxford, United KingdomCCVTM, University of Oxford, Churchill Hospital
May 26, 2022
Non-melanoma Skin Cancer, Carcinoma, Squamous Cell, Carcinoma, Basal Cell Trial in Canada (Nicotinamide, Placebo)
Not yet recruiting
- Non-melanoma Skin Cancer
- +3 more
- Nicotinamide
- Placebo
-
Calgary, Alberta, Canada
- +7 more
Jul 13, 2023
Is COVID-19 Transmitted Through Human Milk? Implications for
Active, not recruiting
- COVID-19 Vaccine
- Breastmilk
- Vaccinated Pregnant or Lactating persons
-
Toronto, Ontario, CanadaSinai Health System
Oct 25, 2022
Primary Brain Tumor Trial in Houston (Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance Spectroscopic Imaging)
Recruiting
- Primary Brain Neoplasm
- Hyperpolarized Carbon C 13 Pyruvate
- Magnetic Resonance Spectroscopic Imaging
-
Houston, TexasM D Anderson Cancer Center
Nov 16, 2022
Heart Failure Trial in Vancouver, Montréal (Us2.ai (AI-enabled report) handheld echocardiogram)
Not yet recruiting
- Heart Failure
- Us2.ai (AI-enabled report) handheld echocardiogram
-
Vancouver, British Columbia, Canada
- +1 more
May 8, 2023
Multiple Sclerosis Trial in London (PIPE-307)
Completed
- Multiple Sclerosis
-
London, United KingdomHammersmith Medicines Research
Oct 4, 2022
Relapsed Adult AML, Refractory AML Trial in Milwaukee (Navitoclax Dose Level -1, Navitoclax Dose Level 0, Navitoclax Dose Level
Not yet recruiting
- Relapsed Adult AML
- Refractory AML
- Navitoclax Dose Level -1
- +10 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Aug 17, 2023
HIV-1-infection Trial in United States (426c.Mod.Core-C4b 30 mcg, 426c.Mod.Core-C4b 100 mcg, 426c.Mod.Core-C4b 300 mcg)
Recruiting
- HIV-1-infection
- 426c.Mod.Core-C4b 30 mcg
- +3 more
-
Birmingham, Alabama
- +5 more
Jul 25, 2022